Clinical Study

Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation

Table 3

Comparison of histological features between A-AIH and C-AIH patients.

Acute
Chronic

G
 001 (2.1%)<0.001
 11 (3.3%)12 (25.0%)
 22 (6.7%)17 (35.4%)
 321 (70.0%)18 (37.5%)
 46 (20.0%)0

S
 002 (4.2%)0.135
 110 (33.3%)20 (41.7%)
 23 (10.0%)10 (20.8%)
 37 (23.3%)4 (8.3%)
 410 (33.3%)12 (25.0%)

Lobular inflammation
 002 (4.2%)
 117 (56.7%)40 (80.3%)
 26 (20.0%)2 (4.2%)
 37 (23.3%)4 (8.3%)

Interface inflammation
 04 (13.3%)13 (27.1%)
 15 (16.7%)21 (43.8%)
 214 (46.7%)11 (22.9%)
 37 (23.3%)3 (6.3%)

Hepatocyte rosettes
 No2 (6.7%)21 (43.8%)<0.001
 Yes28 (93.3%)27 (56.3%)

Periportal lymphocyte
 000<0.001
 11 (3.3%)19 (39.6%)
 229 (96.7%)29 (60.4%)

Periportal plasmocyte
 01 (3.3%)17 (35.4%)<0.001
 115 (50.0%)27 (56.3%)
 214 (46.7%)4 (8.3%)

Periportal neutrophils
 08 (26.7%)28 (58.3%)
 112 (40.0%)16 (33.3%)
 210 (33.3%)4 (8.3%)

Periportal monocyte
 000<0.001
 11 (3.3%)19 (39.6%)
 229 (96.7%)29 (60.4%)

Periportal eosinocyte
 013 (43.3%)36 (75.0%)
 117 (56.7%)12 (25.0%)
 200

Bile duct injury
 05 (16.7%)31 (64.6%)<0.001
 121 (70.0%)17 (35.4%)
 24 (13.3%)0

Centrilobular necrosis
 No20 (66.7%)44 (91.7%)
 Yes10 (33.3%)4 (8.3%)

Lobular neutrophils
 08 (26.7%)40 (83.3%)<
 110 (33.3%)5 (10.4%)
 212 (40.0%)3 (6.3%)

Lobular monocyte
 08 (26.7%)39 (81.3%)<0.001
 111 (36.7%)7 (14.6%)
 211 (36.7%)2 (4.2%)

Lobular eosinocyte
 019 (63.3%)44 (91.7%)
 110 (33.3%)4 (8.3%)
 21 (3.3%)0

Eosinophilic body
 No22 (73.3%)44 (91.7%)0.05
 Yes8 (26.7%)4 (8.3%)

.